Inonoalliacane F

Details

Top
Internal ID 8297e309-1abf-4c76-8668-fb68ad80b521
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Sesquiterpenoids
IUPAC Name (1R,3S,5S,6S,7R,10S)-5,10-dihydroxy-3-(3-hydroxyprop-1-en-2-yl)-6,9,9-trimethyl-2-oxatricyclo[5.3.0.01,3]decan-4-one
SMILES (Canonical) CC1C2CC(C(C23C(O3)(C(=O)C1O)C(=C)CO)O)(C)C
SMILES (Isomeric) C[C@H]1[C@H]2CC([C@@H]([C@@]23[C@](O3)(C(=O)[C@H]1O)C(=C)CO)O)(C)C
InChI InChI=1S/C15H22O5/c1-7(6-16)14-11(18)10(17)8(2)9-5-13(3,4)12(19)15(9,14)20-14/h8-10,12,16-17,19H,1,5-6H2,2-4H3/t8-,9+,10-,12-,14+,15+/m0/s1
InChI Key OILZDBLTKJFYLG-KZDQQRADSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H22O5
Molecular Weight 282.33 g/mol
Exact Mass 282.14672380 g/mol
Topological Polar Surface Area (TPSA) 90.30 Ų
XlogP 0.50
Atomic LogP (AlogP) 0.03
H-Bond Acceptor 5
H-Bond Donor 3
Rotatable Bonds 2

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of Inonoalliacane F

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9812 98.12%
Caco-2 - 0.6577 65.77%
Blood Brain Barrier + 0.6250 62.50%
Human oral bioavailability - 0.6000 60.00%
Subcellular localzation Mitochondria 0.5683 56.83%
OATP2B1 inhibitior - 0.8564 85.64%
OATP1B1 inhibitior + 0.8713 87.13%
OATP1B3 inhibitior + 0.9396 93.96%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.8817 88.17%
BSEP inhibitior - 0.9385 93.85%
P-glycoprotein inhibitior - 0.9171 91.71%
P-glycoprotein substrate - 0.7489 74.89%
CYP3A4 substrate + 0.5857 58.57%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.7914 79.14%
CYP3A4 inhibition - 0.8113 81.13%
CYP2C9 inhibition - 0.7129 71.29%
CYP2C19 inhibition - 0.7550 75.50%
CYP2D6 inhibition - 0.8968 89.68%
CYP1A2 inhibition - 0.7188 71.88%
CYP2C8 inhibition - 0.8916 89.16%
CYP inhibitory promiscuity - 0.6789 67.89%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.9700 97.00%
Carcinogenicity (trinary) Non-required 0.6691 66.91%
Eye corrosion - 0.9812 98.12%
Eye irritation - 0.9262 92.62%
Skin irritation - 0.6581 65.81%
Skin corrosion - 0.9173 91.73%
Ames mutagenesis - 0.5100 51.00%
Human Ether-a-go-go-Related Gene inhibition - 0.7876 78.76%
Micronuclear - 0.6900 69.00%
Hepatotoxicity - 0.6473 64.73%
skin sensitisation - 0.7159 71.59%
Respiratory toxicity - 0.5000 50.00%
Reproductive toxicity + 0.6889 68.89%
Mitochondrial toxicity + 0.7250 72.50%
Nephrotoxicity + 0.7620 76.20%
Acute Oral Toxicity (c) III 0.3942 39.42%
Estrogen receptor binding + 0.6051 60.51%
Androgen receptor binding + 0.6518 65.18%
Thyroid receptor binding + 0.6596 65.96%
Glucocorticoid receptor binding + 0.6146 61.46%
Aromatase binding - 0.5670 56.70%
PPAR gamma - 0.7846 78.46%
Honey bee toxicity - 0.8460 84.60%
Biodegradation - 0.7500 75.00%
Crustacea aquatic toxicity - 0.5500 55.00%
Fish aquatic toxicity + 0.9666 96.66%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL4040 P28482 MAP kinase ERK2 97.01% 83.82%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 94.12% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 91.33% 91.11%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 88.60% 95.56%
CHEMBL1994 P08235 Mineralocorticoid receptor 85.69% 100.00%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 84.86% 85.14%
CHEMBL253 P34972 Cannabinoid CB2 receptor 84.77% 97.25%
CHEMBL3137262 O60341 LSD1/CoREST complex 84.42% 97.09%
CHEMBL1806 P11388 DNA topoisomerase II alpha 82.47% 89.00%
CHEMBL2581 P07339 Cathepsin D 80.37% 98.95%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
There are no matching plants.

Cross-Links

Top
PubChem 139590792
LOTUS LTS0186898
wikiData Q105192596